BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22766791)

  • 21. Utilisation of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues.
    Patócs B; Németh K; Garami M; Arató G; Kovalszky I; Szendroi M; Fekete G
    J Clin Pathol; 2012 Dec; 65(12):1112-8. PubMed ID: 23015660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
    Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
    Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.
    Sadri N; Barroeta J; Pack SD; Abdullaev Z; Chatterjee B; Puthiyaveettil R; Brooks JS; Barr FG; Zhang PJ
    Virchows Arch; 2014 Aug; 465(2):233-9. PubMed ID: 24993903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
    Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
    Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy.
    Park H; Kim H; Hassebroek V; Azuma Y; Slawson C; Azuma M
    J Biol Chem; 2021; 296():100164. PubMed ID: 33293370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
    Surdez D; Zaidi S; Grossetête S; Laud-Duval K; Ferre AS; Mous L; Vourc'h T; Tirode F; Pierron G; Raynal V; Baulande S; Brunet E; Hill V; Delattre O
    Cancer Cell; 2021 Jun; 39(6):810-826.e9. PubMed ID: 33930311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR.
    Rodríguez-Martín C; Alonso J
    Methods Mol Biol; 2021; 2226():85-103. PubMed ID: 33326095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
    Zota V; Siegal GP; Kelly D; Bridge JA; Berglund A; Bui K; Khalil F; R Reed D; Altiok S; Magliocco A; Bui MM
    Fetal Pediatr Pathol; 2023 Apr; 42(2):241-252. PubMed ID: 36062956
    [No Abstract]   [Full Text] [Related]  

  • 30. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
    Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
    Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.
    Desmaze C; Brizard F; Turc-Carel C; Melot T; Delattre O; Thomas G; Aurias A
    Cancer Genet Cytogenet; 1997 Aug; 97(1):12-9. PubMed ID: 9242212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
    Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
    Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ewing-like sarcoma: An emerging family of round cell sarcomas.
    Renzi S; Anderson ND; Light N; Gupta A
    J Cell Physiol; 2019 Jun; 234(6):7999-8007. PubMed ID: 30257034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
    Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
    Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.
    Gamberi G; Cocchi S; Benini S; Magagnoli G; Morandi L; Kreshak J; Gambarotti M; Picci P; Zanella L; Alberghini M
    J Mol Diagn; 2011 May; 13(3):313-24. PubMed ID: 21458383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells.
    Khoogar R; Li F; Chen Y; Ignatius M; Lawlor ER; Kitagawa K; Huang TH; Phelps DA; Houghton PJ
    Cell Oncol (Dordr); 2022 Feb; 45(1):19-40. PubMed ID: 34997546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.